MAUNA KEA TECHNOLOGIES (ALMKT.PA) Stock Fundamental Analysis
Europe - EPA:ALMKT - FR0010609263 - Common Stock
0.0876 EUR
-0.01 (-12.4%)
ALMKT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. ALMKT has a bad profitability rating. Also its financial health evaluation is rather negative. ALMKT has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ALMKT had negative earnings in the past year.
In the past year ALMKT has reported a negative cash flow from operations.
ALMKT had negative earnings in each of the past 5 years.
ALMKT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
ALMKT's Return On Assets of -82.18% is on the low side compared to the rest of the industry. ALMKT is outperformed by 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -82.18% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ALMKT has a Gross Margin of 31.67%. This is in the lower half of the industry: ALMKT underperforms 78.33% of its industry peers.
In the last couple of years the Gross Margin of ALMKT has grown nicely.
The Profit Margin and Operating Margin are not available for ALMKT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.67% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ALMKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALMKT has more shares outstanding
The number of shares outstanding for ALMKT has been increased compared to 5 years ago.
The debt/assets ratio for ALMKT is higher compared to a year ago.
2.2 Solvency
ALMKT has an Altman-Z score of -7.93. This is a bad value and indicates that ALMKT is not financially healthy and even has some risk of bankruptcy.
ALMKT has a Altman-Z score of -7.93. This is amonst the worse of the industry: ALMKT underperforms 88.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -7.93 |
ROIC/WACCN/A
WACC5.87%
2.3 Liquidity
ALMKT has a Current Ratio of 0.23. This is a bad value and indicates that ALMKT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALMKT (0.23) is worse than 91.67% of its industry peers.
ALMKT has a Quick Ratio of 0.23. This is a bad value and indicates that ALMKT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.12, ALMKT is not doing good in the industry: 93.33% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.23 | ||
| Quick Ratio | 0.12 |
3. Growth
3.1 Past
The earnings per share for ALMKT have decreased strongly by -114.81% in the last year.
ALMKT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.96%.
ALMKT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.60% yearly.
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.27%
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%-4.62%
3.2 Future
The Earnings Per Share is expected to grow by 116.79% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALMKT will show a very strong growth in Revenue. The Revenue will grow by 35.72% on average per year.
EPS Next Y90%
EPS Next 2Y116.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year32.89%
Revenue Next 2Y35.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
ALMKT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 0.31, the valuation of ALMKT can be described as very cheap.
ALMKT's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALMKT is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALMKT to the average of the S&P500 Index (34.59), we can say ALMKT is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 0.31 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ALMKT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALMKT's earnings are expected to grow with 116.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y116.79%
EPS Next 3YN/A
5. Dividend
5.1 Amount
ALMKT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ALMKT (11/14/2025, 7:00:00 PM)
0.0876
-0.01 (-12.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners13.62%
Inst Owner ChangeN/A
Ins Owners0.8%
Ins Owner ChangeN/A
Market Cap7.35M
Revenue(TTM)7.66M
Net Income(TTM)-10.40M
Analysts86.67
Price Target0.61 (596.35%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)81.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 0.31 | ||
| P/S | 0.96 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.16
EYN/A
EPS(NY)0.28
Fwd EY317.47%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.09
BVpS-0.35
TBVpS-0.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -82.18% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.67% | ||
| FCFM | N/A |
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
F-Score3
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 12.14% | ||
| Cap/Sales | 3.03% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.23 | ||
| Quick Ratio | 0.12 | ||
| Altman-Z | -7.93 |
F-Score3
WACC5.87%
ROIC/WACCN/A
Cap/Depr(3y)16.65%
Cap/Depr(5y)36.4%
Cap/Sales(3y)2.78%
Cap/Sales(5y)7.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.27%
EPS Next Y90%
EPS Next 2Y116.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%-4.62%
Revenue Next Year32.89%
Revenue Next 2Y35.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-594.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3721.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2418.63%
OCF growth 3YN/A
OCF growth 5YN/A
MAUNA KEA TECHNOLOGIES / ALMKT.PA FAQ
What is the ChartMill fundamental rating of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to ALMKT.PA.
What is the valuation status for ALMKT stock?
ChartMill assigns a valuation rating of 4 / 10 to MAUNA KEA TECHNOLOGIES (ALMKT.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for MAUNA KEA TECHNOLOGIES?
MAUNA KEA TECHNOLOGIES (ALMKT.PA) has a profitability rating of 1 / 10.
What is the financial health of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?
The financial health rating of MAUNA KEA TECHNOLOGIES (ALMKT.PA) is 0 / 10.
Can you provide the expected EPS growth for ALMKT stock?
The Earnings per Share (EPS) of MAUNA KEA TECHNOLOGIES (ALMKT.PA) is expected to grow by 90% in the next year.